About Redbock
Redbock is a Healthcare company based in Encinitas (United States) founded in 2010, and was acquired by NES Global Talent in June 2018. Provider of clinical development, data management, medical writing, and regulatory services. Redbock offers products and services including Resourcing Solutions, Quality Optimization, Regulatory Compliance, Engineering Support, and Clinical Services. Its focus areas include Biopharma Outsourcing and Diversified. Its competitors include ANI Pharmaceuticals, Red Nucleus and Aliada Therapeutics; 1 of its 3 listed competitors has raised funding.
Company details
Redbock was founded in 2010 and is headquartered in Encinitas, United States. Services in clinical development, data management, medical writing, and regulatory affairs are offered within the biopharmaceutical sector. Operations focus on supporting drug development processes for clients in the healthcare industry. Expertise is applied across various stages of clinical trials and compliance requirements, with a presence centered in the U.S. market.
- Headquarters Encinitas, United States
- Stage Acquired
- SectorsHealthcare
- Website redbock.com
- Social LinkedIn
- Acquired by NES Global Talent (Jun 2018)
- Investors
- Acquired byNES Global Talent
(Jun 2018)
Products & Services of Redbock
Redbock offers a comprehensive portfolio of products and services, including Resourcing Solutions, Quality Optimization, Regulatory Compliance, Engineering Support, and Clinical Services.
Offers expert consultants for life science projects and challenges
Enhances productivity in quality systems and procedures
Manages audits and filings for regulated environments
Provides design and validation for products and systems
Supports trials and data management for drugs and devices
Investors in Redbock
Redbock has secured backing from 1 investor. Prominent investors backing the company include NES Global Talent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Online job board is operated for technical and engineering professionals. | 1978 | nesgt.com | Altrincham, United Kingdom |
Investor details for Redbock
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Redbock
98 people are tracked at Redbock (14 in leadership, 84 in team).
| Name | Role | Group |
|---|---|---|
Darren Grainger | Managing Director, Middle East | Leadership |
Shalena Shaheed | Managing Director | Leadership |
Tig Gilliam | Chief Executive Officer | Leadership |
Stephen Buckley | Chief Financial Officer | Leadership |
Peter Burke | Group HR Director | Leadership |
Simon Coton | Chief Operating Officer | Leadership |
Vicki Codd | Marketing Director | Leadership |
Anonymous | Group IT Director | Leadership |
Roland Bruce | Senior Vice President, Americas | Leadership |
Mark Le Vesconte | Finance Director | Leadership |
Lee Coleman | Group Finance Director | Leadership |
Christine Tan | Senior Finance Manager / Head Of Finance | Leadership |
Huseyin Dilberoglu | Chief Human Resources | Leadership |
Ekaterina Konyaeva | Acting Chief Accountant | Leadership |
Aigul Jailaubaeva | Recruitment Specialist | Team |
Venera Baidosova | Recruitment Specialist | Team |
Zhanar Tampekova | Recruitment Specialist | Team |
Basit Saif | Back Office Network Engineer ( STC IGW & Ip/mpls) | Team |
Eleanor Nicholson | Assistant Management Accountant | Team |
Ciro Flores | Sr Document Control Lead | Team |
78 more people are available in the full profile.
Complete people profiles for Redbock
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Redbock
2 dated milestones of Redbock across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Redbock is founded.
- Exit Acquired by NES Global Talent.
Competitors of Redbock
Redbock has 3 listed competitors in our database, 1 of them funded. They include ANI Pharmaceuticals, Red Nucleus and Aliada Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anipharmaceuticals.com | 1996 | Baudette, United States | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | ||
| rednucleus.com | 2014 | Yardley, United States | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | ||
| aliadatx.com | 2021 | Boston, United States | $33M | Provider of drug research & development services for multiple therapeutic areas |
Detailed competitors of Redbock
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Redbock
The website of Redbock (redbock.com) receives about 9.3K visits a month.
- Monthly visits9.3K
▲ 219.1% vs previous month
Websites whose visitors overlap most with Redbock. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
validation.org | validation.org | 100% | #9,714,983 | – | |
| valasciences.com | 98% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Redbock (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Redbock
Complete news archive for Redbock
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redbock
Redbock was founded in 2010.
Redbock is headquartered in Encinitas, United States. It is registered at Encinitas, California, United States.
Redbock was founded in 2010 and is headquartered in Encinitas, United States. Services in clinical development, data management, medical writing, and regulatory affairs are offered within the biopharmaceutical sector. Operations focus on supporting drug development processes for clients in the healthcare industry. Expertise is applied across various stages of clinical trials and compliance requirements, with a presence centered in the U.S. market.
Redbock's top competitors include ANI Pharmaceuticals, Red Nucleus and Aliada Therapeutics.
Redbock offers Resourcing Solutions, Quality Optimization, Regulatory Compliance, Engineering Support, and Clinical Services.
Redbock has 1 investor. Key investors include NES Global Talent.
Yes. Redbock was acquired by NES Global Talent in June 2018.